Treatment-associated severe thrombocytopenia affects survival rate in esophageal cancer patients undergoing concurrent chemoradiotherapy.

Huang, Y M; Wang, C H; Huang, J S; Tsai, C S; Yeh, K Y; Lan, Y J; Wu, T H; Chang, P H; Chang, Y S; Lai, C H

Huang, Y M; Wang, C H; Huang, J S; Tsai, C S; Yeh, K Y; Lan, Y J; Wu, T H; Chang, P H; Chang, Y S; Lai, C H.

Affiliation

Lai CH; Department of Internal Medicine, Divisions of Hematology-Oncology, Chang Gung Memorial Hospital, Keelung, Taiwan.

Indian J Cancer ; 52(3): 454-60, 2015.

Article in En | MEDLINE | ID: mdl-26905168

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Esophageal Neoplasms/complications; Esophageal Neoplasms/drug therapy; Thrombocytopenia/chemically induced; Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Esophageal Neoplasms/mortality; Female; Humans; Male; Middle Aged; Retrospective Studies; Survival Rate; Thrombocytopenia/therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Thrombocytopenia / Esophageal Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Indian J Cancer Year: 2015 Document type: Article

Fulltext

XML

PubMed Links

Search on Google